Neutral impactOrders & Deals
Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?
Economic Times 1 hr ago·30 Jul 2026, 4:03 am
Manipal Health Enterprises is in the second day of its IPO subscription, with the issue currently subscribed 15%. The Grey Market Premium (GMP) has held steady at 2%, suggesting that while there is some interest, investors are approaching the issue with caution. This stability in GMP indicates that the stock is not seeing a rush of speculative buying yet.
For investors, the key takeaway is that the IPO is not seeing an overwhelming response on day two. The modest GMP reflects a wait-and-watch approach. The company plans to use the raised capital for debt repayment and strategic acquisitions, which are positive moves for its long-term growth.
Going forward, investors should watch the subscription status on the final day. A significant jump in subscriptions could boost the stock's listing prospects. Conversely, a flat or declining trend might keep the listing gains modest. The final allotment is expected in early August 2026.
Key takeaways
- Category: Orders & Deals.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
